Refine by
Arterial Disease Suppliers Serving Canada
66 companies found
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
Worldwide, heart disease is the leading cause of death. This is a primary reason why our commitment to your cardiovascular trial couldn’t be stronger. Whether your development program is geared toward treatment or prevention, you will have our ...
based inSanta Clara, CALIFORNIA (USA)
Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic ...
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve ...
based inNeve Ilan, ISRAEL
We have developed a digital X-ray source enabling a cost reduction of medical imaging systems by orders of magnitude. We are a global company planning mass deployment of imaging systems. Our goal is to drive early detection preventive healthcare as ...
Healthcare providers and payers can now benefit from AI medical imaging technology to screen for early signs of chronic disease in large populations. Nanox Ai enables more accurate risk-adjustment so patients are provided with preventative care ...
based inBangalore, INDIA
Stempeutics Research is a leading stem cell company developing stem cell based medicinal products. Stempeutics is an advanced clinical stage Biotech Company based out of Bangalore. It was founded by Manipal Education and Medical Group (MEMG) in 2006 ...
In August 2020, Drug Controller General of India (DCGI) has granted manufacturing and marketing approval of Stempeucel® product for the treatment of CLI due to Buerger’s Disease and CLI due to Atherosclerotic Peripheral ...
based inLeiden, NETHERLANDS
Medis was created in 1989 as a spin-off of the Leiden University Medical Centre (LUMC Netherlands). Our founder and current CSO, Hans Reiber, built the company focusing on X-ray and image analysis of the heart with the mission to make these tools ...
The innovative, vendor-independent post-processing software solution for advanced quantitative analysis of cardiovascular CT ...
based inWest Chester, PENNSYLVANIA (USA)
Portescap offers best-in-class solutions to meet the motion needs of medical and industrial applications. We serve performance-critical motion applications with a broad offering of miniature electronic motor product technologies – brushless DC, ...
based inNew Hope, PENNSYLVANIA (USA)
We are a biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine. Our partnership-enabled business model focuses on forging strategic collaborations with ...
Virtue SAB is a patented drug/device combination product for the treatment of artery disease that delivers a proprietary extended release formulation of sirolimus, SirolimusEFR, during balloon angioplasty without ...
based inHartford, UNITED KINGDOM
Formed in 1989 APC Cardiovascular has earned a reputation as a successful and well-respected healthcare sales and distribution company. We offer direct sales and support for numerous cardiovascular and cardiology product ranges, supplying ...
Using thoracic electrical bioimpedance, the PhysioFlow™ incorporates unique and patented signal waveform morphology analysis algorithm to measure cardiac output and other hemodynamic parameters, thus overcoming the accuracy problems associated ...
based inCalgary, ALBERTA (CANADA)
Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population (SCP). The ...
based inJeddah, SAUDI ARABIA
Gulf Medical Company was founded in 1983 as a medical supply company specialized in the sales and marketing of medical devices and equipment, with the sole proprietorship of the vision “To bring the most innovative state of the art medical ...
based inTampa, FLORIDA (USA)
Concept Medical is driving innovation in medical devices, with a focus on developing technologies for drug delivery with a strong emphasis on intellectual property. Based in Tampa, Florida; Concept Medical has always striven to find solutions to ...
ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease. ...
based inGhislenghien, BELGIUM
DiAgam produces turbidimetric immuno reagents. We are active in the field of Biotechnology. Our R&D department aims its work to developing classical immunology technologies as well as new and innovative technologies based on nanobiotechnologies. ...
C-reactive protein (CRP) is an α1-globulin predominantly synthesized by hepatocytes. It consists of five identical non-glycosylated polypeptide subunits, linked together non-covalently, forming a protein of about 115 kDa. It is composed of few ...
based inWhite Bear Lake, MINNESOTA (USA)
Nextern is a collaborative medical device company. We bring an unmatched core competence in medical device product design and development through manufacturing as a leverageable asset to collaborators like you, who are focused on accelerating the ...
We have expertise in producing microcatheters used in neurovascular, cardiovascular, and peripheral vascular applications. Our goal is to design and manufacture innovative products that provide better patient outcomes and advance the field of ...
based inIrvine, CALIFORNIA (USA)
CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio System combines advanced computational science and artificial intelligence, transforming how cardiovascular disease is ...
based inLodz, POLAND
Angionica Ltd. is a spin-off company whose main goal is the implementation of the innovative Flow Mediated Skin Fluorescence (FMSF) method developed by Lodz University of Technology (TUL) and the Jagiellonian University (UJ). FMSF is a new ...
The FMSF-HS test allows assessment of microcirculatory status based on analysis of baseline oscillations and the reperfusion signal, showing changes in NADH fluorescence due to induced reactive hyperemia ...
based inEmeryville, CALIFORNIA (USA)
Profusa´s mission is to make our body´s chemistry easily accessible to improve health and wellness. We are dedicated to becoming a leader in the development of real-time biosensors that provide unprecedented insights into our overall health status. ...
Profusa’s first clinical offering, the Lumee™ Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. Potential applications include monitoring of compromised ...
based inWolfratshausen, GERMANY
Since ELCAT was founded in 1981, it develops, produced and markets electronic devices for medical technology. Our core competences are in the doppler and plethysmograph product fields. We are a medium-sized company that employs a staff of about 20 ...
the all-round talent with memory function for your bidirectional Doppler sonography, very good sensitivity, Ultrasound Pen Probes, interchangeable ultrasonic modules, Storage of Exams, investigation programs, Voice memo recording, Battery operation ...
based inMont-Saint-Guibert, BELGIUM
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, ...
Genio is the disruptive sleep apnea solution for patients who suffer from moderate to severe Obstructive Sleep Apnea or OSA. Genio is the world’s first and unique battery-free, leadless, full body MR conditional and minimally invasive ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
The LEGFLOW balloon drug coating quality is a major step beyond contemporary first and second generation DCB ...
based inFederal Way, WASHINGTON (USA)
Established in 1987, DiagnosTechs was the first laboratory to introduce saliva hormone testing into routine clinical practice. In 1995, DiagnosTechs added saliva and stool-based gastrointestinal and food sensitivity testing, which expanded the level ...
The Male Hormone Panel measures 7 different hormones involved in male reproductive and sexual functions through a single saliva sample. ...
